Publication Archive - Page 11 sur 18

ROSES-S: Statement from the World Health Organization on the reporting of seroepidemiologic studies for SARS-CoV-2

Short Communication. World Health Organization Seroepidemiology Technical Working Group. Influenza Other Respir Viruses.

2021 June, 26

Available here

World Health Organization. (‎2021)‎. Evaluation of COVID-19 vaccine effectiveness: interim guidance, 17 March 2021. World Health Organization

Patel MK, Bergeri I, Bresee JS, Cowling BJ, Crowcroft NS, Fahmy K, Hirve S, Kang G, Katz MA, Lanata CF, L’Azou Jackson M, Joshi S, Lipsitch M, Mwenda JM, Nogareda F, Orenstein WA, Ortiz JR, Pebody R, Schrag SJ, Smith PG, Srikantiah P, Subissi L, Valenciano M, Vaughn DW, Verani JR, Wilder-Smith A, Feikin DR.

Vaccine. 2021 Jul 5;39(30):4013-4024. doi: 10.1016/j.vaccine.2021.05.099. Epub 2021 Jun 1. PMID: 34119350; PMCID: PMC8166525

Available here

Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project

Kissling E, Hooiveld M, Sandonis Martín V, Martínez-Baz I, William N, Vilcu A-M, Mazagatos C, Domegan L, de Lusignan S, Meijer A, Machado A, Brytting M, Casado I, Murray J-L K., Belhillil S, Larrauri A, O’Donnell J, Tsang R, de Lange M, Rodrigues A P, Riess M, Castilla J, Hamilton M, Falchi A, Pozo F, Dunford L, Cogdale J, Jansen T, Guiomar R, Enkirch T, Burgui C, Sigerson D, Blanchon T, Martínez Ochoa E M, Connell J, Ellis J, van Gageldonk-Lafeber R, Kislaya I, Rose A MC, Valenciano M, I-MOVE-COVID-19 primary care study team.

Europe, December 2020 to May 2021. Euro Surveill. 2021;26(29):pii=2100670

Available here

Global Landscape Review of Serotype-Specific Invasive Pneumococcal Disease Surveillance among Countries Using PCV10/13: The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) Project.

Deloria Knoll M, Bennett JC, Garcia Quesada M, Kagucia EW, Peterson ME, Feikin DR, Cohen AL, Hetrich MK, Yang Y, Sinkevitch JN, Ampofo K, Aukes L, Bacci S, Bigogo G, Brandileone MC, Bruce MG, Camilli R, Castilla J, Chan G, Chanto Chacón G, Ciruela P, Cook H, Corcoran M, Dagan R, Danis K, de Miguel S, De Wals P, Desmet S, Galloway Y, Georgakopoulou T, Hammitt LL, Hilty M, Ho PL, Jayasinghe S, Kellner JD, Kleynhans J, Knol MJ, Kozakova J, Kristinsson KG, Ladhani SN, Lara CS, León ME, Lepp T, Mackenzie GA, Mad’arová L, McGeer A, Mungun T, Mwenda JM, Nuorti JP, Nzoyikorera N, Oishi K, De Oliveira LH, Paragi M, Pilishvili T, Puentes R, Rafai E, Saha SK, Savrasova L, Savulescu C, Scott JA, Scott KJ, Serhan F, Setchanova LP, Sinkovec Zorko N, Skoczyńska A, Swarthout TD, Valentiner-Branth P, van der Linden M, Vestrheim DF, von Gottberg A, Yildirim I, Hayford K; The Pserenade Team.

Microorganisms. 2021 Apr 2;9(4):742. doi: 10.3390/microorganisms9040742. PMID: 33918127; PMCID: PMC8066045.

Available here

Global Landscape Review of Serotype-Specific Invasive Pneumococcal Disease Surveillance among Countries Using PCV10/13: The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) Project. Microorganisms.

Deloria Knoll M, Bennett JC, Garcia Quesada M, Kagucia EW, Peterson ME, Feikin DR, Cohen AL, Hetrich MK, Yang Y, Sinkevitch JN, Ampofo K, Aukes L, Bacci S, Bigogo G, Brandileone MC, Bruce MG, Camilli R, Castilla J, Chan G, Chanto Chacón G, Ciruela P, Cook H, Corcoran M, Dagan R, Danis K, de Miguel S, De Wals P, Desmet S, Galloway Y, Georgakopoulou T, Hammitt LL, Hilty M, Ho PL, Jayasinghe S, Kellner JD, Kleynhans J, Knol MJ, Kozakova J, Kristinsson KG, Ladhani SN, Lara CS, León ME, Lepp T, Mackenzie GA, Mad'arová L, McGeer A, Mungun T, Mwenda JM, Nuorti JP, Nzoyikorera N, Oishi K, De Oliveira LH, Paragi M, Pilishvili T, Puentes R, Rafai E, Saha SK, Savrasova L, Savulescu C, Scott JA, Scott KJ, Serhan F, Setchanova LP, Sinkovec Zorko N, Skoczyńska A, Swarthout TD, Valentiner-Branth P, van der Linden M, Vestrheim DF, von Gottberg A, Yildirim I, Hayford K; The Pserenade Team

2021 Apr 2;9(4):742. doi: 10.3390/microorganisms9040742. PMID: 33918127; PMCID: PMC8066045

Evaluation of COVID-19 vaccine effectiveness

World Health Organization

interim guidance, 17 March 2021

Available here

Absence of association between 2019-20 influenza vaccination and COVID-19: Results of the European I-MOVE-COVID-19 primary care project, March-August 2020.

Kissling E, Hooiveld M, Brytting M, Vilcu AM, de Lange M, Martínez-Baz I, Sigerson D, Enkirch T, Belhillil S, Meijer A, Castilla J, William N, Carnahan A, Falchi A, Hendriksen J, Casado I, Murray J, Enouf V, Dijkstra F, Marques DFP, Valenciano M

Influenza Other Respir Viruses. 2021 Jul;15(4):429-438. doi: 10.1111/irv.12839. Epub 2021 Jan 22. PMID: 33481344; PMCID: PMC8013620.

Available here

Interim 2019/20 influenza vaccine effectiveness: six European studies, September 2019 to January 2020.

Rose Angela, Kissling Esther, Emborg Hanne-Dorthe, Larrauri Amparo, McMenamin Jim, Pozo Francisco, Trebbien Ramona, Mazagatos Clara, Whitaker Heather, Valenciano Marta, European IVE group

Euro Surveill. 2020;25(10):pii=2000153.

Available here

A data driven clinical algorithm for differential diagnosis of pertussis and other respiratory infections in infants

Tozzi AE, Gesualdo F, Rizzo C, Carloni E, Russo L, Campagna I, et al. (2020)

PLoS ONE 15(7): e0236041

Available here

Vaccine effectiveness against influenza A(H3N2) and B among laboratory-confirmed, hospitalised older adults, Europe, 2017-18: A season of B lineage mismatched to the trivalent vaccine.

Rose AMC, Kissling E, Gherasim A, et al.

Influenza Other Respir Viruses. 2020 May;14(3):302-310. DOI: 10.1111/irv.12714. PMID: 32022450; PMCID: PMC7182608

Available here

Publication

Référencement Centrales d'achats

Hébergement de données de santé

Engagement et éthique